Over the past 12 months, 0 insiders at Satsuma Pharmaceuticals, Inc. filed 0 open-market SEC Form 4 transactions on STSA: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 8, 23 | Shin Nippon Biomedical Laboratories, Ltd.TenPercentOwner | BUY | 8.42M | $0.91 | $7.7M |
| Jun 6, 23 | Shin Nippon Biomedical Laboratories, Ltd.TenPercentOwner | BUY | 22.05M | $0.91 | $20.1M |
| Jun 6, 23 | Ken TakanashiDirector,TenPercentOwner | BUY | 22.05M | $0.91 | $20.1M |
| Nov 21, 22 | Braden Michael LeonardTenPercentOwner | BUY | 150.0K | $0.71 | $107K |
| Nov 15, 22 | Braden Michael LeonardTenPercentOwner | BUY | 531.0K | $0.63 | $335K |
| Nov 14, 22 | Commodore Capital LpTenPercentOwner | SELL | 3.25M | $0.71 | $2.3M |
| Nov 14, 22 | Braden Michael LeonardTenPercentOwner | BUY | 5.61M | $0.69 | $3.9M |
| Nov 24, 21 | Commodore Capital LpTenPercentOwner | BUY | 2.9K | $5.42 | $16K |
| Nov 22, 21 | Commodore Capital LpTenPercentOwner | BUY | 10.0K | $5.49 | $55K |
| Nov 19, 21 | Commodore Capital LpTenPercentOwner | BUY | 3.2K | $5.44 | $18K |
| Nov 11, 21 | Commodore Capital LpTenPercentOwner | BUY | 7.9K | $6.05 | $48K |
| Nov 10, 21 | Commodore Capital LpTenPercentOwner | BUY | 9.6K | $5.85 | $56K |
| Nov 8, 21 | Commodore Capital LpTenPercentOwner | BUY | 560 | $5.99 | $3K |
| Nov 5, 21 | Commodore Capital LpTenPercentOwner | BUY | 7.8K | $5.95 | $46K |
| Nov 4, 21 | Commodore Capital LpTenPercentOwner | BUY | 1.4K | $5.88 | $8K |
| Nov 2, 21 | Commodore Capital LpTenPercentOwner | BUY | 8.9K | $5.64 | $50K |
| Oct 29, 21 | Commodore Capital LpTenPercentOwner | BUY | 44.7K | $5.71 | $255K |
| Oct 28, 21 | Commodore Capital LpTenPercentOwner | BUY | 15.1K | $5.55 | $84K |
| Oct 27, 21 | Commodore Capital LpTenPercentOwner | BUY | 39.6K | $5.45 | $216K |
| Oct 22, 21 | Commodore Capital LpTenPercentOwner | BUY | 27.6K | $5.51 | $152K |
| Oct 21, 21 | Commodore Capital LpTenPercentOwner | BUY | 32.8K | $5.40 | $177K |
| Oct 20, 21 | Commodore Capital LpTenPercentOwner | BUY | 40.7K | $5.44 | $221K |
| Oct 19, 21 | Commodore Capital LpTenPercentOwner | BUY | 87.6K | $5.07 | $444K |
| Oct 18, 21 | Commodore Capital LpTenPercentOwner | BUY | 36.2K | $4.87 | $176K |
| Oct 15, 21 | Commodore Capital LpTenPercentOwner | BUY | 126.0K | $4.83 | $609K |
Over the past 12 months, insiders at Satsuma Pharmaceuticals, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on STSA, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market STSA insider purchase in our data was $20.1M by Shin Nippon Biomedical Laboratories, Ltd., TenPercentOwner, filed on Jun 6, 23.
0 different insiders at Satsuma Pharmaceuticals, Inc. filed open-market SEC Form 4 transactions on STSA over the last 12 months.
InsiderTape plots every STSA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Satsuma Pharmaceuticals, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →